Novartis Investigative Site

's-Hertogenbosch, North Brabant 5223 LA

1 studies enrolling now · 3 studies all time

What they study most

Alzheimers Disease, Primary Prevention of Atherosclerotic Cardiovascular Disease, Secondary Progressive Multiple Sclerosis (SPMS)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease — Stopped early